Maria Lyng

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

Meredith M. Regan, Brian Leyland‐Jones, Mark Bouzyk et al. · JNCI Journal of the National Cancer Institute · 2012 · 338 citations · Full text

Novel circulating microRNA signature as a potential non‐invasive multi‐marker test in ER‐positive early‐stage breast cancer: A case control study

Annette Raskov Kodahl, Maria Lyng, Harald Binder et al. · Molecular Oncology · 2014 · 185 citations · Full text

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence

Jian Yuan Goh, Min Feng, Wenyu Wang et al. · Nature Medicine · 2017 · 152 citations

Chromatin, Systems Biology, Breast Cancer Recurrence +14

Identification of genes for normalization of real-time RT-PCR data in breast carcinomas

Maria Lyng, Anne‐Vibeke Lænkholm, Niels Pallisgaard et al. · BMC Cancer · 2008 · 113 citations · Full text

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

Karina Gravgaard Thomsen, Maria Lyng, Anne‐Vibeke Lænkholm et al. · Breast Cancer Research and Treatment · 2012 · 96 citations

Breast Oncology, Metastatic Tissue, Breast Cancer +7